1,3-DIHYDRO-3-(HYDROXYMETHYLENE)-4-(4-METHYL-1-PIPERAZINYL)-2H-1,5-BENZODIAZEPINE-2-THIONE
UNII L3LS9C74PM
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,3-dihydro-3-(hydroxymethylene)-4-(4-methyl-1-piperazinyl)-2h-1,5-benzodiazepine-2-thione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L3LS9C74PM.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1320360-86-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C15H18N4OS AHLVAHJPLRKOQZ-KHPPLWFESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,3-dihydro-3-(hydroxymethylene)-4-(4-methyl-1-piperazinyl)-2h-1,5-benzodiazepine-2-thione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.